Influence of Bariatric Surgery on Remission of Type 2 Diabetes
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
The plague of obesity afflicts an increasing group of people. Moreover type 2 diabetes, which is the most serious illness accompanying excessive weight, is becoming more and more common. Traditional methods of obesity treatment, such as diet and physical exercise, fail. This applies especially to people with class III obesity. The only successful way of treating obesity in their case is bariatric surgery. There are three types of bariatric surgery: restrictive procedures (reducing stomach volume), malabsorptive procedures, and mixed procedures, which combine both methods. In spite of the risk connected with the surgery and complications after it, bariatric procedures are advised to patients with class III obesity and class II with an accompanying illness which increases the probability of death. It has been proved that bariatric surgery not only eliminates obesity but also very frequently (in 90% of cases) leads to the remission of type 2 diabetes. Moreover, the remission occurs very fast – it takes place a long time before the patients reduce their weight, even within a few days after surgery. Detailed studies have shown that the remission of diabetes is caused mostly by the change of the gastro-intestinal hormones’ profile, resulting from the surgery. These hormones include GLP-1, GIP, peptide YY, ghrelin and oxyntomodulin. Additionally, the change of the amount of adipose tissue after the surgery influences the level of adipokines, i.e. the hormones of the adipose tissue, among which the most important are leptin, adiponectin and resistin. Thus, bariatric surgery not only changes the shape of the gastrointestinal tract but it also modulates the hormonal activity. Bariatric surgery is considered as therapy not only for the obese but also for diabetic patients.
Authors and Affiliations
Paweł Nalepa, Aleksandra Piechnik, Anna Kiersztan
Molecular mechanisms regulating metastasis of cancer cells with special emphasis on rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is a malignant tumor of soft tissue derived from embryonic mesenchymal and/or neuroectodermal tissues. It is most often associated with other genetic syndromes such as Li-Fraumeni or Bechwith-Wiede...
Prozdrowotna rola kwercetyny obecnej w diecie człowieka
Kwercetyna jest fitozwiązkiem z grupy flawonoidów roślinnych wykazującym szeroki zakres właściwości, m.in. antyoksydacyjnych, przeciwzapalnych i immunomodulacyjnych. Bierze udział w regulacji wielu procesów komórkowych,...
TGF-β1 i elastaza granulocytów w ocenie aktywności nieswoistych chorób zapalnych jelit. Badanie pilotażowe
Chemotherapy and plasma adipokines level in patients with colorectal cancer
Adipokines are molecules produced and secreted by adipose tissue and are linked to multiple malignancies. Adipokines can suppress or promote particular cell behaviors in different types of cancer. The aim of this study w...
Czynniki Yamanaki i rdzeniowe czynniki transkrypcyjne – molekularne ogniwa między embriogenezą i karcynogenezą
Czynniki transkrypcyjne Oct4, Sox2 (należące do rodziny czynników Yamanaki) oraz Nanog, zwane rdzeniowymi czynnikami transkrypcyjnymi pluripotencji, odgrywają główną rolę w indukowaniu i podtrzymywaniu stanu pluripotencj...